{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T12:40:41Z","timestamp":1754397641080,"version":"3.37.3"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T00:00:00Z","timestamp":1538092800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T00:00:00Z","timestamp":1538092800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Sanofi-Aventis Deutschland GmbH","award":["n.a."],"award-info":[{"award-number":["n.a."]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herz"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s00059-018-4746-7","type":"journal-article","created":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T05:48:26Z","timestamp":1538113706000},"page":"483-492","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Lipidprofil und kardiovaskul\u00e4res Risiko der Teilnehmer an den Lipidmesstagen im Industriepark H\u00f6chst","Lipid profile and cardiovascular risk of participants in the lipid measurement program in the industrial park in H\u00f6chst"],"prefix":"10.1007","volume":"45","author":[{"given":"M.","family":"Christmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Rosada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Ferlinz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4970-2110","authenticated-orcid":false,"given":"P.","family":"Bramlage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Steinhagen-Thiessen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,28]]},"reference":[{"key":"4746_CR1","volume-title":"Gesundheit \u2013 Todesursachen in Deutschland, Fachserie 12, Reihe 4","author":"Statistisches Bundesamt, Wiesbaden","year":"2015","unstructured":"Statistisches Bundesamt, Wiesbaden (2015) Gesundheit \u2013 Todesursachen in Deutschland, Fachserie 12, Reihe 4. \n                  https:\/\/www.destatis.de\/DE\/ZahlenFakten\/GesellschaftStaat\/Gesundheit\/Todesursachen\/Tabellen\/EckdatenTU.html\n                  \n                . Zugegriffen: 1.\u00a0Juni 2017"},{"key":"4746_CR2","volume-title":"Krankheitskosten. Gesundheitsberichterstattung des Bundes. Heft\u00a048","author":"Robert Koch-Institut","year":"2009","unstructured":"Robert Koch-Institut (2009) Krankheitskosten. Gesundheitsberichterstattung des Bundes. Heft\u00a048. RKI, Berlin"},{"issue":"39","key":"4746_CR3","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1093\/eurheartj\/ehw272","volume":"37","author":"AL Catapano","year":"2016","unstructured":"Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, Hoes AW, Jennings CS, Landmesser U, Pedersen TR et\u00a0al (2016) 2016 ESC\/EAS guidelines for the management of dyslipidaemias. Eur Heart\u00a0J 37(39):2999\u20133058","journal-title":"Eur Heart J"},{"issue":"9438","key":"4746_CR4","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","volume":"364","author":"S Yusuf","year":"2004","unstructured":"Yusuf S, Hawken S, \u00d4unpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J et al (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364(9438):937\u2013952","journal-title":"Lancet"},{"issue":"9493","key":"4746_CR5","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","volume":"366","author":"C Baigent","year":"2005","unstructured":"Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R et al (2005) Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 366(9493):1267\u20131278","journal-title":"Lancet"},{"issue":"1","key":"4746_CR6","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1161\/HCQ.0000000000000014","volume":"9","author":"JP Drozda Jr.","year":"2016","unstructured":"Drozda JP Jr., Ferguson TB Jr., Jneid H, Krumholz HM, Nallamothu BK, Olin JW, Ting HH, Heidenreich PA, Albert NM, Chan PS et\u00a0al (2016) 2015 ACC\/AHA focused update of secondary prevention lipid performance measures: a report of the American College of Cardiology\/American Heart Association Task Force on Performance Measures. Circ Cardiovasc Qual Outcomes 9(1):68\u201395","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"05","key":"4746_CR7","doi-asserted-by":"publisher","first-page":"R37","DOI":"10.1055\/s-0032-1325445","volume":"7","author":"M Merkel","year":"2012","unstructured":"Merkel M, M\u00fcller-Wieland D (2012) Lipidtherapie bei Diabetes mellitus. Diabetol Stoffwechsel 7(05):R37\u2013R50","journal-title":"Diabetol Stoffwechsel"},{"issue":"9153","key":"4746_CR8","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/S0140-6736(98)07368-1","volume":"353","author":"P Gaede","year":"1999","unstructured":"Gaede P, Vedel P, Parving HH, Pedersen O (1999) Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study. Lancet 353(9153):617\u2013622","journal-title":"Lancet"},{"key":"4746_CR9","unstructured":"Das F\u00fcnfte Buch Sozialgesetzbuch \u2013 Gesetzliche Krankenversicherung \u2013 (Artikel 1 des Gesetzes vom 20. Dezember 1988 BIS, 2482), das durch Artikel 1 des Gesetzes vom 15. Juli 2013 (BGBl. I S.\u00a02423) ge\u00e4ndert worden ist; 2017."},{"issue":"3","key":"4746_CR10","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1161\/hc0302.102575","volume":"105","author":"G Assmann","year":"2002","unstructured":"Assmann G, Cullen P, Schulte H (2002) Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study. Circulation 105(3):310\u2013315","journal-title":"Circulation"},{"issue":"Suppl A","key":"4746_CR11","first-page":"A2","volume":"19","author":"G Assmann","year":"1998","unstructured":"Assmann G, Cullen P, Schulte H (1998) The Munster Heart Study (PROCAM). Results of follow-up at 8 years. Eur Heart\u00a0J 19(Suppl A):A2\u2013A11","journal-title":"Eur Heart J"},{"issue":"7","key":"4746_CR12","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/0002-9149(92)90550-I","volume":"70","author":"G Assmann","year":"1992","unstructured":"Assmann G, Schulte H (1992) Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Prospective Cardiovascular Munster study. Am J Cardiol 70(7):733\u2013737","journal-title":"Am J Cardiol"},{"issue":"12","key":"4746_CR13","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1007\/s00103-005-1164-9","volume":"48","author":"L Pieper","year":"2005","unstructured":"Pieper L, Wittchen HU, Glaesmer H, Klotsche J, Marz W, Stalla G, Lehnert H, Zeiher AM, Silber S, Koch U et al (2005) Cardiovascular high-risk constellations in primary care. DETECT Study 2003. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 48(12):1374\u20131382","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"issue":"3","key":"4746_CR14","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1097\/00004872-200403000-00009","volume":"22","author":"AM Sharma","year":"2004","unstructured":"Sharma AM, Wittchen HU, Kirch W, Pittrow D, Ritz E, Goke B, Lehnert H, Tschope D, Krause P, Hofler M et al (2004) High prevalence and poor control of hypertension in primary care: cross-sectional study. J\u00a0Hypertens 22(3):479\u2013486","journal-title":"J Hypertens"},{"issue":"6","key":"4746_CR15","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/hr.2014.40","volume":"37","author":"C Balijepalli","year":"2014","unstructured":"Balijepalli C, Bramlage P, Losch C, Zemmrich C, Humphries KH, Moebus S (2014) Prevalence and control of high blood pressure in primary care: results from the German Metabolic and Cardiovascular Risk Study (GEMCAS). Hypertens Res 37(6):580\u2013584","journal-title":"Hypertens Res"},{"issue":"11","key":"4746_CR16","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s00392-010-0177-z","volume":"99","author":"AK Gitt","year":"2010","unstructured":"Gitt AK, Junger C, Smolka W, Bestehorn K (2010) Prevalence and overlap of different lipid abnormalities in statin-treated patients at high cardiovascular risk in clinical practice in Germany. Clin Res Cardiol 99(11):723\u2013733","journal-title":"Clin Res Cardiol"},{"key":"4746_CR17","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.dib.2016.09.037","volume":"9","author":"AK Gitt","year":"2016","unstructured":"Gitt AK, Lautsch D, Ferrieres J, Kastelein J, Drexel H, Horack M, Brudi P, Vanneste B, Bramlage P, Chazelle F et al (2016) Contemporary data on low-density lipoprotein cholesterol target value attainment and distance to target in a\u00a0cohort of 57,885 statin-treated patients by country and region across the world. Data Brief 9:616\u2013620","journal-title":"Data Brief"},{"key":"4746_CR18","first-page":"71","volume":"9","author":"JR Schaefer","year":"2013","unstructured":"Schaefer JR, Gitt AK, Sonntag F, Weizel A, Jannowitz C, Karmann B, Pittrow D, Bestehorn K (2013) Lipid management in 13,000 high risk cardiovascular patients treated under daily practice conditions: LIMA registry. Vasc Health Risk Manag 9:71\u201380","journal-title":"Vasc Health Risk Manag"},{"issue":"6","key":"4746_CR19","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1177\/2047487315569401","volume":"23","author":"K Kotseva","year":"2016","unstructured":"Kotseva K, Wood D, De Bacquer D, De Backer G, Ryden L, Jennings C, Gyberg V, Amouyel P, Bruthans J, Castro Conde A et\u00a0al (2016) EUROASPIRE IV: a European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries. Eur J Prev Cardiol 23(6):636\u2013648","journal-title":"Eur J Prev Cardiol"},{"key":"4746_CR20","first-page":"247","volume":"8","author":"L Laforest","year":"2012","unstructured":"Laforest L, Ambegaonkar BM, Souchet T, Sazonov V, Van Ganse E (2012) Mixed dyslipidemias in primary care patients in France. Vasc Health Risk Manag 8:247\u2013254","journal-title":"Vasc Health Risk Manag"},{"issue":"3","key":"4746_CR21","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1024\/0301-1526\/a000611","volume":"46","author":"M Scheerbaum","year":"2017","unstructured":"Scheerbaum M, Langenbach C, Scheerbaum P, Heidemann F, Riess HC, Heigel H, Debus SE, Behrendt CA (2017) Prevalence of cardiovascular risk factors among 28,000 employees. VASA 46(3):203\u2013210","journal-title":"VASA"},{"issue":"2","key":"4746_CR22","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s00392-004-0990-3","volume":"93","author":"DB Gysan","year":"2004","unstructured":"Gysan DB, Latsch J, Bjarnason-Wehrens B, Albus C, Falkowski G, Herold G, Mey E, Heinzler R, Montiel G, Schneider CA et al (2004) The PreFord Study. Z\u00a0Kardiol 93(2):131\u2013136 (A prospective cohort study to evaluate the risk of a cardiovascular event (overall-collective) as well as a prospective, randomized, controlled, multicentre clinical intervention study (high-risk-collective) on primary prevention of cardiovascular diseases in the Ford Motor Company employees in Germany)","journal-title":"Z Kardiol"},{"key":"4746_CR23","unstructured":"Verteilungsprofil kardiovaskul\u00e4rer Risikofaktoren und deren Erfassung mittels computergest\u00fctzter Risikoscores: Vergleichende Analyse des ESC-, Deutschland\u2011, Framingham und PROCAM-Scores im Rahmen der Pr\u00e4Ford-Studie [esport.dshs-koeln.de\/13\/1\/Dissertation_Stefan_T\u00fcrk.pdf]"},{"issue":"2","key":"4746_CR24","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/HJR.0b013e3283294b1d","volume":"16","author":"K Kotseva","year":"2009","unstructured":"Kotseva K, Wood D, De Backer G, De Bacquer D, Pyorala K, Keil U (2009) EUROASPIRE III: a\u00a0survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. Eur J Cardiovasc Prev Rehabil 16(2):121\u2013137","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"4746_CR25","volume-title":"Cardiovascular disease and diabetes: policies for better health and quality of care","author":"Organisation for Economic Co-operation and Development (OECD)","year":"2015","unstructured":"Organisation for Economic Co-operation and Development (OECD) (2015) Cardiovascular disease and diabetes: policies for better health and quality of care. OECD Publishing, Paris"},{"issue":"8","key":"4746_CR26","first-page":"1596","volume":"7","author":"S Reddy Kilim","year":"2013","unstructured":"Reddy Kilim S, Chandala SR (2013) A comparative study of lipid profile and oestradiol in pre- and post-menopausal women. J\u00a0Clin Diagn Res 7(8):1596\u20131598","journal-title":"J Clin Diagn Res"},{"issue":"29","key":"4746_CR27","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","volume":"37","author":"MF Piepoli","year":"2016","unstructured":"Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, Corra U, Cosyns B, Deaton C et\u00a0al (2016) 2016 European guidelines on cardiovascular disease prevention in clinical practice. Eur Heart\u00a0J 37(29):2315\u20132381 (The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR))","journal-title":"Eur Heart J"},{"issue":"18","key":"4746_CR28","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1001\/archinte.162.18.2046","volume":"162","author":"F Forette","year":"2002","unstructured":"Forette F, Seux ML, Staessen JA, Thijs L, Babarskiene MR, Babeanu S, Bossini A, Fagard R, Gil-Extremera B, Laks T et al (2002) The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study. Arch Intern Med 162(18):2046\u20132052","journal-title":"Arch Intern Med"},{"issue":"5\/6","key":"4746_CR29","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s00103-013-1669-6","volume":"56","author":"H Neuhauser","year":"2013","unstructured":"Neuhauser H, Thamm M, Ellert U (2013) Blood pressure in Germany 2008\u20132011: results of the German Health Interview and Examination Survey for Adults (DEGS1). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 56(5\/6):795\u2013801","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"issue":"7","key":"4746_CR30","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1097\/00004872-199007000-00012","volume":"8","author":"YR Schlussel","year":"1990","unstructured":"Schlussel YR, Schnall PL, Zimbler M, Warren K, Pickering TG (1990) The effect of work environments on blood pressure: evidence from seven New York organizations. J\u00a0Hypertens 8(7):679\u2013685","journal-title":"J Hypertens"},{"key":"4746_CR31","volume-title":"Hypertonie in Klinik und Praxis","author":"T Lenz","year":"2008","unstructured":"Lenz T (2008) Hypertonie in Klinik und Praxis. Schattauer, Stuttgart"},{"issue":"6\/7","key":"4746_CR32","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s00103-012-1498-z","volume":"55","author":"A Gosswald","year":"2012","unstructured":"Gosswald A, Lange M, Kamtsiuris P, Kurth BM (2012) DEGS: German Health Interview and Examination Survey for Adults. A nationwide cross-sectional and longitudinal study within the framework of health monitoring conducted by the Robert Koch Institute. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 55(6\/7):775\u2013780","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"issue":"4","key":"4746_CR33","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1056\/NEJMoa1012848","volume":"366","author":"JD Berry","year":"2012","unstructured":"Berry JD, Dyer A, Cai X, Garside DB, Ning H, Thomas A, Greenland P, Van Horn L, Tracy RP, Lloyd-Jones DM (2012) Lifetime risks of cardiovascular disease. N\u00a0Engl J Med 366(4):321\u2013329","journal-title":"N Engl J Med"},{"issue":"1","key":"4746_CR34","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s12181-016-0114-0","volume":"11","author":"R Hambrecht","year":"2017","unstructured":"Hambrecht R, Albus C, Halle M, Landmesser U, L\u00f6llgen H, Schuler GC, Perings S (2017) Kommentar zu den neuen Leitlinien (2016) der Europ\u00e4ischen Gesellschaft f\u00fcr Kardiologie (ESC) zur kardiovaskul\u00e4ren Pr\u00e4vention. Kardiologe 11(1):21\u201326","journal-title":"Kardiologe"},{"issue":"12","key":"4746_CR35","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1001\/jama.2016.13985","volume":"316","author":"MG Silverman","year":"2016","unstructured":"Silverman MG, Ference BA, Im K, Wiviott SD, Giugliano RP, Grundy SM, Braunwald E, Sabatine MS (2016) Association between lowering LDL-C and cardiovascular risk reduction among different therapeutic interventions: a systematic review and meta-analysis. JAMA 316(12):1289\u20131297","journal-title":"JAMA"},{"issue":"2","key":"4746_CR36","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1177\/1741826711400545","volume":"19","author":"AK Gitt","year":"2012","unstructured":"Gitt AK, Drexel H, Feely J, Ferrieres J, Gonzalez-Juanatey JR, Thomsen KK, Leiter LA, Lundman P, da Silva PM, Pedersen T et al (2012) Persistent lipid abnormalities in statin-treated patients and predictors of LDL-cholesterol goal achievement in clinical practice in Europe and Canada. Eur J Prev Cardiol 19(2):221\u2013230","journal-title":"Eur J Prev Cardiol"},{"issue":"15","key":"4746_CR37","first-page":"261","volume":"113","author":"KG Parhofer","year":"2016","unstructured":"Parhofer KG (2016) The treatment of disorders of lipid metabolism. Dtsch Arztebl Int 113(15):261\u2013268","journal-title":"Dtsch Arztebl Int"},{"key":"4746_CR38","unstructured":"Lifestyle Changes for Heart Attack Prevention \n                  www.heart.org\/en\/health-topics\/heart-attack\/life-after-a-heart-attack\/lifestyle-changes-for-heart-attack-prevention\n                  \n                . Zugegriffen: 31.\u00a0Juli 2015"},{"issue":"1","key":"4746_CR39","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/phn.12222","volume":"33","author":"J Cooper","year":"2016","unstructured":"Cooper J, Zimmerman W (2016) The evaluation of a\u00a0regional faith community network\u2019s million hearts program. Public Health Nurs 33(1):53\u201364","journal-title":"Public Health Nurs"},{"issue":"1","key":"4746_CR40","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.cjca.2014.10.034","volume":"31","author":"BJ O\u2019Neill","year":"2015","unstructured":"O\u2019Neill BJ, Rana SN, Bowman V (2015) An integrated approach for vascular health: a\u00a0call to action. Can J Cardiol 31(1):99\u2013102","journal-title":"Can J Cardiol"},{"issue":"3","key":"4746_CR41","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1007\/s00059-017-4554-5","volume":"43","author":"P Bramlage","year":"2018","unstructured":"Bramlage P, Marz W, Westermann D, Weisser B, Wirtz JH, Zeymer U, Baumgart P, van Mark G, Laufs U, Kramer BK et\u00a0al (2018) Management of different cardiovascular risk factors with a\u00a0combination tablet (polypill). Herz 43(3):246\u2013257","journal-title":"Herz"},{"key":"4746_CR42","unstructured":"Effekte einer multimodalen Intervention auf das kardiovaskul\u00e4re Risikoprofil ausgew\u00e4hlter Hochrisikopatienten in der Prim\u00e4rpr\u00e4vention von Herz-Kreislauferkrankungen \u2013 Ergebnisse der Pr\u00e4Ford-Studie [\n                  http:\/\/esport.dshs-koeln.de\/466\/\n                  \n                ]"}],"container-title":["Herz"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-018-4746-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00059-018-4746-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-018-4746-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T20:08:00Z","timestamp":1596312480000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00059-018-4746-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,28]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["4746"],"URL":"https:\/\/doi.org\/10.1007\/s00059-018-4746-7","relation":{},"ISSN":["0340-9937","1615-6692"],"issn-type":[{"type":"print","value":"0340-9937"},{"type":"electronic","value":"1615-6692"}],"subject":[],"published":{"date-parts":[[2018,9,28]]},"assertion":[{"value":"4 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"M.\u00a0Christmann, A.\u00a0Rosada, K.\u00a0Ferlinz, P.\u00a0Bramlage und E.\u00a0Steinhagen-Thiessen geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}